Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 5, Issue 3
February 9 2021
Issue Cover

Table of Contents

CLINICAL GUIDELINES

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker,Eric K. Tseng,Robby Nieuwlaat,Pantep Angchaisuksiri,Clifton Blair,Kathryn Dane,Jennifer Davila,Maria T. DeSancho,David Diuguid,Daniel O. Griffin,Susan R. Kahn,Frederikus A. Klok,Alfred Ian Lee,Ignacio Neumann,Ashok Pai,Menaka Pai,Marc Righini,Kristen M. Sanfilippo,Deborah Siegal,Mike Skara,Kamshad Touri,Elie A. Akl,Imad Bou Akl,Mary Boulos,Romina Brignardello-Petersen,Rana Charide,Matthew Chan,Karin Dearness,Andrea J. Darzi,Philipp Kolb,Luis E. Colunga-Lozano,Razan Mansour,Gian Paolo Morgano,Rami Z. Morsi,Atefeh Noori,Thomas Piggott,Yuan Qiu,Yetiani Roldan,Finn Schünemann,Adrienne Stevens,Karla Solo,Matthew Ventresca,Wojtek Wiercioch,Reem A. Mustafa,Holger J. Schünemann
View Articletitled, American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Supplemental data

EXCEPTIONAL CASE REPORT

A patient with a germline GATA2 mutation and primary myelofibrosis
Clinical Trials & Observations
Cyrill V. Rütsche,Eugenia Haralambieva,Veronika Lysenko,Stefan Balabanov,Alexandre P. A. Theocharides
View Articletitled, A patient with a germline <em>GATA2</em> mutation and primary myelofibrosis
Supplemental data

STIMULUS REPORTS

Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19
Christophe Guervilly,Amandine Bonifay,Stephane Burtey,Florence Sabatier,Raphaël Cauchois,Evelyne Abdili,Laurent Arnaud,Guillaume Lano,Léa Pietri,Thomas Robert,Mélanie Velier,Laurent Papazian,Jacques Albanese,Gilles Kaplanski,Françoise Dignat-George,Romaric Lacroix
View Articletitled, Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19
Supplemental data
Pembrolizumab in mycosis fungoides with PD-L1 structural variants
Clinical Trials & Observations
Sara Beygi,Sebastian Fernandez-Pol,George Duran,Erica B. Wang,Henning Stehr,James L. Zehnder,Nirasha Ramchurren,Steven P. Fling,Martin A. Cheever,Wen-Kai Weng,Youn H. Kim,Michael S. Khodadoust
View Articletitled, Pembrolizumab in mycosis fungoides with PD-L1 structural variants
Low 5-year health care burden after umbilical cord blood transplantation
Jesus Garcia Garcia,Sonya Grillo,Qing Cao,Claudio G. Brunstein,Mukta Arora,Margaret L. MacMillan,John E. Wagner,Daniel J. Weisdorf,Shernan G. Holtan
View Articletitled, Low 5-year health care burden after umbilical cord blood transplantation

REVIEW ARTICLE

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
Chaja F. Jacobs,Eric Eldering,Arnon P. Kater
View Articletitled, Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Clinical Trials & Observations
Andrei Shustov,Maria Elena Cabrera,Monica Civallero,Monica Bellei,Young Hyeh Ko,Martina Manni,Tetiana Skrypets,Steven M. Horwitz,Carmino Antonio De Souza,John A. Radford,Sabela Bobillo,Maria Virginia Prates,Andrés J. M. Ferreri,Carlos Chiattone,Michele Spina,Julie M. Vose,Annalisa Chiappella,Daniele Laszlo,Dario Marino,Caterina Stelitano,Massimo Federico,on behalf of the T-cell Lymphoma Project
View Articletitled, ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study
Clinical Trials & Observations
Evangelos Terpos,Noopur Raje,Peter Croucher,Ramon Garcia-Sanz,Xavier Leleu,Waltraud Pasteiner,Yang Wang,Anthony Glennane,Jude Canon,Charlotte Pawlyn
View Articletitled, Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Constitutive activation of NF-κB during early bone marrow development results in loss of B cells at the pro-B-cell stage
Andrea Paun,Estefania Claudio,Ulrich K. Siebenlist
View Articletitled, Constitutive activation of NF-κB during early bone marrow development results in loss of B cells at the pro-B-cell stage
Supplemental data
PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations
Clinical Trials & Observations
Patricia A. Olofsen,Dennis A. Bosch,Onno Roovers,Paulina M. H. van Strien,Hans W. J. de Looper,Remco M. Hoogenboezem,Sander Barnhoorn,Pier G. Mastroberardino,Mehrnaz Ghazvini,Vincent H. J. van der Velden,Eric M. J. Bindels,Emma M. de Pater,Ivo P. Touw
View Articletitled, PML-controlled responses in severe congenital neutropenia with <em>ELANE</em>-misfolding mutations
Supplemental data
Unexpected redundancy of Gpr56 and Gpr97 during hematopoietic cell development and differentiation
Antonio Maglitto,Samanta A. Mariani,Emma de Pater,Carmen Rodriguez-Seoane,Chris S. Vink,Xianhua Piao,Mari-Liis Lukke,Elaine Dzierzak
View Articletitled, Unexpected redundancy of Gpr56 and Gpr97 during hematopoietic cell development and differentiation
Supplemental data
JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells
Hannah Lawson,Catarina Sepulveda,Louie N. van de Lagemaat,Jozef Durko,Melania Barile,Andrea Tavosanis,Elise Georges,Alena Shmakova,Penny Timms,Roderick N. Carter,Lewis Allen,Joana Campos,Milica Vukovic,Amelie V. Guitart,Peter Giles,Marie O’Shea,Douglas Vernimmen,Nicholas M. Morton,Neil P. Rodrigues,Berthold Göttgens,Christopher J. Schofield,Andreas Lengeling,Dónal O’Carroll,Kamil R. Kranc
View Articletitled, JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells
Supplemental data

LYMPHOID NEOPLASIA

Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features
Clinical Trials & Observations
Xiaolong Alan Zhou,Jingyi Yang,Kimberly G. Ringbloom,Maria Estela Martinez-Escala,Kristen E. Stevenson,Alexander T. Wenzel,Damiano Fantini,Haley K. Martin,Andrea P. Moy,Elizabeth A. Morgan,Shannon Harkins,Christian N. Paxton,Bo Hong,Erica F. Andersen,Joan Guitart,David M. Weinstock,Lorenzo Cerroni,Jaehyuk Choi,Abner Louissaint, Jr
View Articletitled, Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features
Supplemental data
Adenylate kinase 2 expression and addiction in T-ALL
Nabih Maslah,Mehdi Latiri,Vahid Asnafi,Mélanie Féroul,Nawel Bedjaoui,Thomas Steimlé,Emmanuelle Six,Els Verhoyen,Elizabeth Macintyre,Chantal Lagresle-Peyrou,Ludovic Lhermitte,Guillaume P. Andrieu
View Articletitled, Adenylate kinase 2 expression and addiction in T-ALL
Supplemental data
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma
Clinical Trials & Observations
Panayiotis Panayiotidis,George A. Follows,Luigina Mollica,Arnon Nagler,Muhit Özcan,Armando Santoro,Don Stevens,David Trevarthen,Florian Hiemeyer,Jose Garcia-Vargas,Barrett H. Childs,Pier Luigi Zinzani,Martin Dreyling
View Articletitled, Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma
Supplemental data

MYELOID NEOPLASIA

Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation
Michelle C. Krutein,Matthew R. Hart,Donovan J. Anderson,Jasmin Jeffery,Andriana G. Kotini,Jin Dai,Sylvia Chien,Michaela DelPriore,Sara Borst,Jean Ann Maguire,Deborah L. French,Paul Gadue,Eirini P. Papapetrou,Siobán B. Keel,Pamela S. Becker,Marshall S. Horwitz
View Articletitled, Restoring RUNX1 deficiency in <em>RUNX1</em> familial platelet disorder by inhibiting its degradation
Supplemental data
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
Blake S. Moses,Samantha McCullough,Jennifer M. Fox,Bryan T. Mott,Søren M. Bentzen,MinJung Kim,Jeffrey W. Tyner,Rena G. Lapidus,Ashkan Emadi,Michelle A. Rudek,Tami J. Kingsbury,Curt I. Civin
View Articletitled, Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
Supplemental data
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial
Clinical Trials & Observations
Catia Simoes,Bruno Paiva,David Martínez-Cuadrón,Juan-Miguel Bergua,Susana Vives,Lorenzo Algarra,Mar Tormo,Pilar Martinez,Josefina Serrano,Pilar Herrera,Fernando Ramos,Olga Salamero,Esperanza Lavilla,Cristina Gil,Jose-Luis Lopez,Maria-Belen Vidriales,Jorge Labrador,Jose-Francisco Falantes,María-José Sayas,Rosa Ayala,Joaquin Martinez-Lopez,Sara Villar,Maria-Jose Calasanz,Felipe Prosper,Jesús F. San-Miguel,Miguel Ángel Sanz,Pau Montesinos,on behalf of the Programa para el Estudio de la Terapéutica en Hemopatías Malignas (PETHEMA) Cooperative Study Group
View Articletitled, Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial
Supplemental data
Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
Svea Stratmann,Sara A. Yones,Markus Mayrhofer,Nina Norgren,Aron Skaftason,Jitong Sun,Karolina Smolinska,Jan Komorowski,Morten Krogh Herlin,Christer Sundström,Anna Eriksson,Martin Höglund,Josefine Palle,Jonas Abrahamsson,Kirsi Jahnukainen,Monica Cheng Munthe-Kaas,Bernward Zeller,Katja Pokrovskaja Tamm,Lucia Cavelier,Linda Holmfeldt
View Articletitled, Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

A zebrafish model of granulin deficiency reveals essential roles in myeloid cell differentiation
Clyde A. Campbell,Oksana Fursova,Xiaoyi Cheng,Elizabeth Snella,Abbigail McCune,Liangdao Li,Barbara Solchenberger,Bettina Schmid,Debashis Sahoo,Mark Morton,David Traver,Raquel Espín-Palazón
View Articletitled, A zebrafish model of granulin deficiency reveals essential roles in myeloid cell differentiation
Supplemental data

THROMBOSIS AND HEMOSTASIS

Fibrin-modulating nanogels for treatment of disseminated intravascular coagulation
Emily P. Mihalko,Megan Sandry,Nicholas Mininni,Kimberly Nellenbach,Halston Deal,Michael Daniele,Kamrouz Ghadimi,Jerrold H. Levy,Ashley C. Brown
View Articletitled, Fibrin-modulating nanogels for treatment of disseminated intravascular coagulation
Supplemental data
Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arterial thrombosis
Tony G. Walsh,Yong Li,Christopher M. Williams,Elizabeth W. Aitken,Robert K. Andrews,Alastair W. Poole
View Articletitled, Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arterial thrombosis
Supplemental data
Molecular coevolution of coagulation factor VIII and von Willebrand factor
Philip M. Zakas,Christopher W. Coyle,Anja Brehm,Marion Bayer,Barbara Solecka-Witulska,Caelan E. Radford,Christine Brown,Kate Nesbitt,Courtney Dwyer,Christoph Kannicht,H. Trent Spencer,Eric A. Gaucher,Christopher B. Doering,David Lillicrap
View Articletitled, Molecular coevolution of coagulation factor VIII and von Willebrand factor
Supplemental data

TRANSFUSION MEDICINE

Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions
Clinical Trials & Observations
Sarah J. Waldis,Stacey Uter,Donna Kavitsky,Cynthia Flickinger,Sunitha Vege,David F. Friedman,Connie M. Westhoff,Stella T. Chou
View Articletitled, Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions
Supplemental data

TRANSPLANTATION

Allogeneic stem cell transplantation with omidubicel in sickle cell disease
Clinical Trials & Observations
Suhag Parikh,Joel A. Brochstein,Einat Galamidi,Aurélie Schwarzbach,Joanne Kurtzberg
View Articletitled, Allogeneic stem cell transplantation with omidubicel in sickle cell disease
Supplemental data
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience
Clinical Trials & Observations
Katie Maurer,Anna Saucier,Haesook T. Kim,Utkarsh Acharya,Clifton C. Mo,Julie Porter,Cindy Albert,Corey Cutler,Joseph H. Antin,John Koreth,Mahasweta Gooptu,Rizwan Romee,Catherine J. Wu,Robert J. Soiffer,Sarah Nikiforow,Caron Jacobson,Vincent T. Ho
View Articletitled, COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience
Supplemental data

VASCULAR BIOLOGY

Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
Clinical Trials & Observations
Erica Villa,Rosina Critelli,Simone Lasagni,Alessandra Melegari,Angela Curatolo,Ciro Celsa,Dante Romagnoli,Gabriele Melegari,Alessandra Pivetti,Lorenza Di Marco,Federico Casari,Dimitriy Arioli,Fabrizio Turrini,Valentina Zuccaro,Irene Cassaniti,Mattia Riefolo,Elena de Santis,Veronica Bernabucci,Marcello Bianchini,Barbara Lei,Nicola De Maria,Lucia Carulli,Filippo Schepis,Chiara Gozzi,Silvio Malaguti,Mariagrazia Del Buono,Lucio Brugioni,Pietro Torricelli,Tommaso Trenti,Giovanni Pinelli,Elisabetta Bertellini,Raffaele Bruno,Calogero Cammà,Antonia d’Errico
View Articletitled, Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
Supplemental data

COMMENTARIES

Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19
Younes Zaid,Fadila Guessous,Florian Puhm,Wail Elhamdani,Lamyae Chentoufi,Andrew Conway Morris,Amine Cheikh,Farid Jalali,Eric Boilard,Louis Flamand
View Articletitled, Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19
Supplemental data
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
Fien A. von Meijenfeldt,Sebastian Havervall,Jelle Adelmeijer,Annika Lundström,Maria Magnusson,Nigel Mackman,Charlotte Thalin,Ton Lisman
View Articletitled, Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
Impact of treatment delay in acute myeloid leukemia revisited
Clinical Trials & Observations
Gunnar Juliusson,Oskar Hagberg,Vladimir Lj Lazarevic,Sören Lehmann,Martin Höglund,for the Swedish AML Registry
View Articletitled, Impact of treatment delay in acute myeloid leukemia revisited
Supplemental data
All Issues

Advertisement

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
Phillips NS, Mulrooney DA, Williams AM, et al. Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma. Blood Adv. 2023;7(23):7270-7278.
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
Race and ethnicity reporting and representation in hemophilia clinical trials

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement